Drug utilization among young adults with atopic dermatitis: Influence of sex, socio‐economic status and disease severity

Abstract

AbstractBackgroundAtopic dermatitis (AD) affects individuals of all ages, and the first‐line treatment are emollients and topical corticosteroids. There is insufficient knowledge about factors possibly affecting the drug utilization of young adults with AD.ObjectivesTo describe the drug utilization of young adults with AD in relation to sex, socio‐economic status and disease severity.MethodsA cross‐sectional study based on the 24‐year follow‐up from the population‐based BAMSE (Children, Allergy, Milieu, Stockholm, Epidemiology Survey) birth cohort linked with dispensing data from the National Drug Register (n = 2912). Self‐reported AD and socio‐economic status were defined from questionnaire data and disease severity was determined through the clinical examination and Patient‐Oriented Eczema Measure questionnaire.ResultsThe prevalence of AD in young adults was 17.7% (n = 516) and 45.5% of them were dispensed at least one drug for the treatment of AD during the study period (January 2016 to June 2019). Topical corticosteroids (TCS) were the most common drugs (32.9%) followed by emollients (21.7%). A larger proportion of men were dispensed TCS than women (39.0% vs. 29.1%: p‐value = 0.020). A larger proportion of young adults with moderate‐to‐severe AD were dispensed TCS than those with mild AD (52.6% vs. 35.3%: p‐value = 0.026). No one was dispensed the recommended amount of emollients and less than five individuals were dispensed the recommended amount of TCS for mild disease. Male sex (adj.OR 1.54, 95% CI 1.06–2.34) and moderate‐to‐severe AD (adj.OR 2.62, 95% CI 1.59–4.31) were associated with dispensation of TCS.ConclusionsA large proportion of young adults with AD was undertreated or untreated. Sex and disease severity did affect the dispensing patterns of investigated drugs.